But the two-year Crestor results actually rival the cleaning done by the so-called "artery Drano" ETC-216, a "good cholesterol" drug that lowered the plaque volume by 4% in 47 patients in only five weeks.
The water is more of a stream than the whoosh we would like, and the Drano isn't extra-strength, but like any other country there's an economic cycle, and I think that's primarily responsible for the stagnation we see here.